Octagon Capital Advisors LP Pharvaris N.V. Transaction History
Octagon Capital Advisors LP
- $263 Million
- Q2 2025
A detailed history of Octagon Capital Advisors LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 672,595 shares of PHVS stock, worth $14.6 Million. This represents 4.49% of its overall portfolio holdings.
Number of Shares
672,595
Previous 769,815
12.63%
Holding current value
$14.6 Million
Previous $12.1 Million
2.06%
% of portfolio
4.49%
Previous 4.02%
Shares
5 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$163 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$95.5 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$92.9 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$79.1 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$71.5 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $731M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...